Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Macimorelin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aeterna Zentaris Provides Update on Macrilen (Macimorelin)
    Aeterna Zentaris Provides Update on Macrilen (Macimorelin)

    05 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/05/2641603/0/en/Aeterna-Zentaris-Provides-Update-on-Macrilen-Macimorelin-Reiterates-Advancement-of-Pediatric-DETECT-Trial.html

    GLOBENEWSWIRE
    05 Apr 2023
    Share Share
    Aeterna Zentaris Set to Regain Full Rights to Macrilen™ (Macimorelin)
    Aeterna Zentaris Set to Regain Full Rights to Macrilen™ (Macimorelin)

    29 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/29/2505902/0/en/Aeterna-Zentaris-Set-to-Regain-Full-Rights-to-Macrilen-Macimorelin-in-U-S-and-Canada-from-Novo-Nordisk.html

    GLOBENEWSWIRE
    29 Aug 2022
    Share Share
    AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY
    AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY

    30 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/30/2070270/0/en/AETERNA-ZENTARIS-ANNOUNCES-ABSTRACT-OF-RESULTS-FROM-FIRST-PEDIATRIC-STUDY-OF-MACIMORELIN-ACCEPTED-FOR-PRESENTATION-AT-THE-22ND-EUROPEAN-CONGRESS-OF-ENDOCRINOLOGY.html

    GLOBENEWSWIRE
    30 Jul 2020
    Share Share
    EMA committee recommends approval for 4 medicine
    EMA committee recommends approval for 4 medicine

    20 Nov 2018

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=112362&sid=2

    PHARMABIZ
    20 Nov 2018
    Share Share
    Meeting highlights from Committee for Medicinal Products for Human Use 12-15 Nov, 18
    Meeting highlights from Committee for Medicinal Products for Human Use 12-15 Nov, 18

    17 Nov 2018

    // EMA

    https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-november-2018

    EMA
    17 Nov 2018
    Share Share
    Aeterna Zentaris Announces FDA Approval of Macrilen™ (macimorelin)
    Aeterna Zentaris Announces FDA Approval of Macrilen™ (macimorelin)

    20 Dec 2017

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2017/12/20/1267302/0/en/Aeterna-Zentaris-Announces-FDA-Approval-of-Macrilen-macimorelin-for-Diagnosis-of-Adult-Growth-Hormone-Deficiency.html

    GLOBENEWSWIRE
    20 Dec 2017
    Share Share